Study guide
Section 2.4: Impaired Pharmacists & Peer Review Programs
Texas MPJE Pharmacy Jurisprudence Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Pharmacy Law Foundations & Regulators
Section 1.1: State and Federal Regulatory Bodies Section 1.2: Structure of Texas Pharmacy Law Section 1.3: TSBP Powers and Administrative Procedures Section 1.4: Inspections, Investigations, and Discipline
2 Chapter 2: Pharmacist Licensure & Continuing Education
Section 2.1: Initial Pharmacist Licensure & Reciprocity Section 2.2: License Renewal & Continuing Education Requirements Section 2.3: Inactive Status, Reinstatement, and Administrative Changes Section 2.4: Impaired Pharmacists & Peer Review Programs
3 Chapter 3: Pharmacy Personnel & Supervision Ratios
Section 3.1: Pharmacist-in-Charge (PIC) Responsibilities and Duties Section 3.2: Pharmacy Technicians and Technician Trainees Section 3.3: Pharmacist-to-Technician Supervision Ratios Section 3.4: Duties of Supportive Personnel
4 Chapter 4: Pharmacy Permits & Facility Classifications
Section 4.1: Texas Pharmacy Permit Classes Section 4.2: Class A (Community) Operations & Facilities Section 4.3: Class C (Institutional/Hospital) Operations & Facilities Section 4.4: Central Processing (Class G) and Non-Resident (Class E)
5 Chapter 5: Prescribers & Prescription Validity
Section 5.1: Texas Prescriptive Authority Section 5.2: General Prescription Requirements Section 5.3: Out-of-State and Canadian/Mexican Prescriptions Section 5.4: Self-Prescribing & Prescribing for Family Members
6 Chapter 6: Controlled Substances Schedules & Registration
Section 6.1: Federal vs. Texas Controlled Substances Schedules Section 6.2: DEA Registration & Texas Controlled Substances Act Section 6.3: Scheduled Listed Chemical Products Section 6.4: Controlled Substance Theft or Loss Reporting
7 Chapter 7: Controlled Substances Prescriptions & Dispensing
Section 7.1: CII Prescription Requirements and Validity Section 7.2: CII Refills, Partial Fills, and Emergency Oral Dispensing Section 7.3: CIII-CV Prescription Requirements, Validity, Refills, and Partial Fills Section 7.4: Opioid 10-day Initial Supply Limit & PMP Mandatory Queries
8 Chapter 8: Prescription Monitoring Program (PMP) & Drug Abuse
Section 8.1: Texas Prescription Monitoring Program Reporting & Database Section 8.2: Naloxone Access and Standing Orders in Texas Section 8.3: Corresponding Responsibility & Red Flags of Diversion Section 8.4: Treatment of Substance Use Disorders
9 Chapter 9: Dispensing Standards & Generic Substitution
Section 9.1: Texas Generic Substitution Law Section 9.2: Patient Counseling and Drug Utilization Review Requirements Section 9.3: Prescription Labeling Requirements in Texas Section 9.4: Poison Prevention Packaging Act & Child-Resistant Containers
10 Chapter 10: Prescription Refills, Transfers & Emergency Dispensing
Section 10.1: Prescription Refill Refusal & Professional Judgment Section 10.2: Prescription Transfer Rules Section 10.3: Emergency Refills (72-hour rule & 30-day natural disaster rule) Section 10.4: Return and Reuse of Prescription Medications
11 Chapter 11: Pharmacy Operations, Security & Recordkeeping
Section 11.1: Pharmacy Security, Alarms & Delivery of Drugs in Texas Section 11.2: General Recordkeeping & Document Retention Requirements Section 11.3: Controlled Substance Inventories Section 11.4: Disposal and Destruction of Controlled Substances
12 Chapter 12: Compounding Standards (Sterile & Non-Sterile)
Section 12.1: Non-Sterile Compounding Regulations Section 12.2: Sterile Compounding Regulations Section 12.3: Hazardous Drug Handling Section 12.4: Compounding Recordkeeping & Quality Control
13 Chapter 13: Specialized Pharmacy Practice & Public Safety
Section 13.1: Collaborative Practice Agreements & Drug Therapy Management Section 13.2: Pharmacist Immunization Authority & Protocol Requirements Section 13.3: Automated Dispensing Devices (Class A, C, and remote sites) Section 13.4: Public Health Laws (HIPAA, OBRA-90, DSCSA Drug Track and Trace)
Section 2.4: Impaired Pharmacists & Peer Review Programs
Key Takeaways Explain This Topic AI
Texas pharmacy law treats impairment as a medical condition under Chapter 564 of the Occupations Code.
The Professional Recovery Network (PRN) is a peer assistance program operated by the Texas Pharmacy Association, not the TSBP.
Self-referrals to PRN are confidential, whereas board-ordered participation is public and reported to the TSBP.
PRN contracts impose practice restrictions, such as prohibiting the participant from serving as a PIC or working alone.
Pharmacy peer review committees evaluate quality of care and receive civil immunity and strict record confidentiality.
Last updated: July 2026
Impaired Pharmacists & Peer Review Programs
The practice of pharmacy is highly demanding, and substance use disorders, chemical dependency, and mental health conditions are recognized occupational hazards. To address these issues while protecting public safety, Texas pharmacy law provides specialized mechanisms: the Professional Recovery Network (PRN) for impaired professionals and pharmacy peer review committees for quality assurance.
1. Impaired Professionals & Legislative Intent
Under the Texas Pharmacy Act (Chapter 564 of the Texas Occupations Code) and the Texas Health & Safety Code (Chapter 467) , the state recognizes that professional impairment should be treated as a medical and psychological condition rather than solely a disciplinary violation.
Purpose: The legislative intent is to encourage impaired pharmacy professionals to seek help early, rehabilitate, and safely return to practice. This approach prioritizes public safety by providing a non-punitive path to recovery, reducing the likelihood that impaired professionals will hide their conditions and risk patient harm.
Eligible Individuals: The program covers licensed pharmacists, registered pharmacy technicians, registered technician trainees, and pharmacy student-interns.
2. The Professional Recovery Network (PRN)
The Professional Recovery Network (PRN) is the official peer assistance program approved by the TSBP.
Independence: An important legal nuance is that PRN is not run by the TSBP . Instead, it is operated independently by the Texas Pharmacy Association (TPA) . Funding is provided in part by a surcharge on pharmacist and pharmacy licensing fees collected by the TSBP, but the day-to-day operations are separate from the Board to foster trust and encourage self-reporting.
Confidentiality Rules: The level of confidentiality a participant receives depends entirely on their pathway into the program:
Self-Referral: If a pharmacist contacts PRN directly for help, their participation is completely confidential . The TSBP is not notified of the pharmacist's identity, and no disciplinary action is taken, provided the pharmacist complies with all evaluation and treatment recommendations and does not pose an imminent danger to the public.
Third-Party Referral: If a colleague, employer, or family member reports an impaired pharmacist to PRN, PRN will contact the pharmacist and encourage them to enter the program. If the pharmacist agrees to participate and complies with the program, their identity remains confidential from the TSBP. However, if they refuse to cooperate, PRN is legally required to report their name to the TSBP, triggering a formal board investigation.
Board-Ordered Referral: If the TSBP discovers a pharmacist's impairment (e.g., through an arrest for DUI, a drug diversion investigation, or a complaint), the Board may issue a disciplinary order requiring the pharmacist to participate in PRN. In this case, participation is not confidential . The disciplinary order is a public record, and PRN must report the pharmacist's compliance, drug test results, and progress directly to the Board.
3. The Recovery Support Agreement (PRN Contract)
When a licensee enters PRN, they must sign a legally binding Recovery Support Agreement (typically lasting 2 to 5 years; 5 years is standard for pharmacists).
Key Contract Requirements:
Evaluation by a Board-approved psychiatrist or addiction medicine specialist.
Completion of recommended treatment programs (inpatient or outpatient).
Attendance at support group meetings (e.g., Alcoholics Anonymous or Narcotics Anonymous) and PRN peer support groups.
Participation in random, observed drug and alcohol screenings (which can occur multiple times per month).
Regular reports from the participant's therapist, sponsor, and employer.
Practice Restrictions: While under a PRN contract, a pharmacist's practice is strictly controlled to minimize stress and prevent access to controlled substances if necessary:
No PIC Roles: Participants are prohibited from serving as a Pharmacist-in-Charge (PIC).
No Solo Practice: Participants cannot work alone; another licensed pharmacist must be on duty at all times.
Hours Limitations: They are typically restricted to working a maximum of 40 hours per week.
No Supervision: They cannot supervise student-interns or serve as a registered preceptor.
Non-Compliance: If a participant fails a drug screen, refuses to submit to a screen, or violates any term of their contract, PRN must notify the TSBP within 24 to 48 hours. This typically results in an immediate emergency temporary suspension of the pharmacist's license by the Board, followed by disciplinary proceedings.
4. Pharmacy Peer Review Committees
Apart from peer assistance for impairment, Texas law allows pharmacies to establish Pharmacy Peer Review Committees to evaluate the quality of care provided by the pharmacy and its staff.
Function: These committees review dispensing errors, analyze system failures, recommend procedural improvements, and evaluate the professional competency of pharmacists.
Voluntary vs. Mandated: Establishing a peer review committee is generally voluntary for pharmacies. However, the TSBP can mandate the creation of a peer review program as part of a disciplinary order against a pharmacy permit holder.
Confidentiality & Privilege: To encourage honest self-evaluation, all proceedings, documents, records, and communications of a pharmacy peer review committee are strictly confidential and privileged . They cannot be subpoenaed or used as evidence in civil lawsuits (such as medical malpractice cases).
Immunity from Liability: Any person who provides information to, testifies before, or serves on a pharmacy peer review committee in good faith is immune from civil liability for doing so. This protects pharmacists from retaliation or lawsuits when reporting professional errors or concerns about a colleague's competency.
PRN Program Pathways Comparison
Criteria / Feature Self-Referral Pathway Third-Party Referral Pathway Board-Ordered Pathway
Confidentiality Fully confidential from TSBP Confidential from TSBP if compliant Not confidential; public record
TSBP Notification None (unless non-compliant) None (unless non-compliant or refuses) Yes; regular reports to TSBP
Practice Restrictions Imposed based on clinical evaluation Imposed based on clinical evaluation Imposed via Board Disciplinary Order